High expression of ALDH1A3 in MES-GSCs induced mesenchymal differentiation [17], rapid intracranial tumor growth, and invasiveness [18], thereby leading to an aggressive progression of the tumor. The gene discussed is ALDH1A3; the disease is neoplasm.